Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesAn initial payment of $3.0 million has been made, with the potential for an additional approximately $6.0 million in gross proceeds upon the full exercise of warrants in cash.
